Network Point of Care Glucose Testing Market Size, Trends, Analysis, and Outlook By Product (i-STAT, Accu-Chek Inform II, StatStrip, HemoCue, CareSens Expert Plus, BAROzen H Expert Plus), by Region, Country, Segment, and Companies, 2024-2030

March 2024 | 190 pages | ID: NB3D66432EEBEN
VPAResearch

Abstracts

The global Network Point of Care Glucose Testing market size is poised to register 4.32% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Network Point of Care Glucose Testing market across By Product (i-STAT, Accu-Chek Inform II, StatStrip, HemoCue, CareSens Expert Plus, BAROzen H Expert Plus).

The Network Point of Care Glucose Testing market is experiencing robust growth driven by the increasing prevalence of diabetes, technological advancements in point-of-care testing devices, and the growing adoption of network-connected glucose monitoring solutions in healthcare settings. Network point-of-care glucose testing refers to the decentralized testing of blood glucose levels at or near the point of patient care, enabling rapid diagnosis, treatment decisions, and monitoring of diabetes management. Key drivers of market growth include the rising incidence of diabetes worldwide, the need for timely and accurate glucose monitoring in clinical settings, and the integration of wireless connectivity and cloud-based data management features into point-of-care testing devices. Additionally, the development of compact, user-friendly glucose meters, continuous glucose monitoring (CGM) systems, and smartphone-connected glucose monitoring apps is driving innovation in the market. Moreover, the implementation of diabetes management protocols, telemedicine initiatives, and remote patient monitoring programs is driving the adoption of network point-of-care glucose testing solutions. Furthermore, regulatory approvals, reimbursement policies, and strategic partnerships between medical device manufacturers, healthcare providers, and technology companies are driving market competitiveness and ensuring the widespread adoption of network-connected glucose testing solutions in the management of diabetes.

Network Point of Care Glucose Testing Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Network Point of Care Glucose Testing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Network Point of Care Glucose Testing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Network Point of Care Glucose Testing industry.

Key market trends defining the global Network Point of Care Glucose Testing demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Network Point of Care Glucose Testing Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Network Point of Care Glucose Testing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Network Point of Care Glucose Testing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Network Point of Care Glucose Testing industry

Leading Network Point of Care Glucose Testing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Network Point of Care Glucose Testing companies.

Network Point of Care Glucose Testing Market Study- Strategic Analysis Review

The Network Point of Care Glucose Testing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-

• Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
• Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
• Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
• Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.

Network Point of Care Glucose Testing Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Network Point of Care Glucose Testing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Network Point of Care Glucose Testing Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Network Point of Care Glucose Testing Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Network Point of Care Glucose Testing market segments. Similarly, Strong end-user demand is encouraging Canadian Network Point of Care Glucose Testing companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Network Point of Care Glucose Testing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Network Point of Care Glucose Testing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Network Point of Care Glucose Testing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Network Point of Care Glucose Testing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Network Point of Care Glucose Testing Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Network Point of Care Glucose Testing in Asia Pacific. In particular, China, India, and South East Asian Network Point of Care Glucose Testing markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Network Point of Care Glucose Testing Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Network Point of Care Glucose Testing Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Network Point of Care Glucose Testing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Network Point of Care Glucose Testing.

Network Point of Care Glucose Testing Market Company Profiles

The global Network Point of Care Glucose Testing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott, Bayer AG, Danaher, F. Hoffmann-La Roche Ltd, Nova Biomedical

Recent Network Point of Care Glucose Testing Market Developments

The global Network Point of Care Glucose Testing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Network Point of Care Glucose Testing Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis

• Pricing Analysis
• Value Chain Analysis
• SWOT Profile
• Market Dynamics- Trends, Drivers, Challenges
• Porter’s Five Forces Analysis
• Macroeconomic Impact Analysis
• Case Scenarios- Low, Base, High

Market Segmentation:

By Product

i-STAT

Accu-Chek Inform II

StatStrip

HemoCue

CareSens Expert Plus

BAROzen H Expert Plus

Geographical Segmentation:

• North America (3 markets)
• Europe (6 markets)
• Asia Pacific (6 markets)
• Latin America (3 markets)
• Middle East Africa (5 markets)

Companies

Abbott

Bayer AG

Danaher

F. Hoffmann-La Roche Ltd

Nova Biomedical

Formats Available: Excel, PDF, and PPT

Contents

1. EXECUTIVE SUMMARY

1.1 Network Point of Care Glucose Testing Market Overview and Key Findings, 2024
1.2 Network Point of Care Glucose Testing Market Size and Growth Outlook, 2021- 2030
1.3 Network Point of Care Glucose Testing Market Growth Opportunities to 2030
1.4 Key Network Point of Care Glucose Testing Market Trends and Challenges
  1.4.1 Network Point of Care Glucose Testing Market Drivers and Trends
  1.4.2 Network Point of Care Glucose Testing Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Network Point of Care Glucose Testing Companies

2. NETWORK POINT OF CARE GLUCOSE TESTING MARKET SIZE OUTLOOK TO 2030

2.1 Network Point of Care Glucose Testing Market Size Outlook, USD Million, 2021- 2030
2.2 Network Point of Care Glucose Testing Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024

3. NETWORK POINT OF CARE GLUCOSE TESTING MARKET- STRATEGIC ANALYSIS REVIEW

3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis

4. NETWORK POINT OF CARE GLUCOSE TESTING MARKET SEGMENTATION ANALYSIS AND OUTLOOK

4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
i-STAT
Accu-Chek Inform II
StatStrip
HemoCue
CareSens Expert Plus
BAROzen H Expert Plus
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030

5. REGION-WISE MARKET OUTLOOK TO 2030

5.1 Key Findings for Asia Pacific Network Point of Care Glucose Testing Market, 2025
5.2 Asia Pacific Network Point of Care Glucose Testing Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Network Point of Care Glucose Testing Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Network Point of Care Glucose Testing Market, 2025
5.5 Europe Network Point of Care Glucose Testing Market Size Outlook by Type, 2021- 2030
5.6 Europe Network Point of Care Glucose Testing Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Network Point of Care Glucose Testing Market, 2025
5.8 North America Network Point of Care Glucose Testing Market Size Outlook by Type, 2021- 2030
5.9 North America Network Point of Care Glucose Testing Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Network Point of Care Glucose Testing Market, 2025
5.11 South America Pacific Network Point of Care Glucose Testing Market Size Outlook by Type, 2021- 2030
5.12 South America Network Point of Care Glucose Testing Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Network Point of Care Glucose Testing Market, 2025
5.14 Middle East Africa Network Point of Care Glucose Testing Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Network Point of Care Glucose Testing Market Size Outlook by Application, 2021- 2030

6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030

6.1 US Network Point of Care Glucose Testing Market Size Outlook and Revenue Growth Forecasts
6.2 US Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Network Point of Care Glucose Testing Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Network Point of Care Glucose Testing Industry Drivers and Opportunities

7. NETWORK POINT OF CARE GLUCOSE TESTING MARKET OUTLOOK ACROSS SCENARIOS

7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case

8. NETWORK POINT OF CARE GLUCOSE TESTING COMPANY PROFILES

8.1 Profiles of Leading Network Point of Care Glucose Testing Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott
Bayer AG
Danaher
F. Hoffmann-La Roche Ltd
Nova Biomedical

9. APPENDIX

9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information